University of Nottingham Repository
metadata only
The development of a synthetic self-adjuvanting cancer vaccine
Cancer testis antigens (CTA) have demonstrated high immunogenicity towards multiple cancer types, and due to their restricted expression profile, they warrant further attention as potential vaccine candidates. Covalently attaching an adjuvant to an antigen is an effective strategy to induce a strong
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer#863368
- A Screening Study Targeting Tumor-specific Antigens#238092
- Vaccine Study for Surgically Resected Pancreatic Cancer#481792
- Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors#467633
- Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer#390953
Record · ID 1160087
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive